C4: CRITICAL CLEANING FOR CONTAMINATION CONTROL - For Regulation of Nanotechnology: See the FDA

摘要

This column is a follow-up to the excellent article by Barry Bark, Ph.D., and Dr. Steffi Friedrichs in the April issue of Controlled Environments Magazine titled "Safe Nanotechnology: Overcoming Challenges and Assessing Risk in Bringing Applications to Market." That article focused on the absence of published guidance on the handling and disposal of nanoparticles and other nanoscale entities, and assessment of the risks associated with development and use of nanomaterials. This column will report on a significant step in U.S. management of nanomaterials -- a role for the U.S. Food and Drug Administration (FDA), and probably raise more questions than it answers.